Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2023-11-21 Regulatory Filings
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
SOCAMAINE, CENTRALE D'ACHATS E. LECLERC, PROPOSE LE BILAN DE PRÉVENTION DU CANCER DU SEIN À SES SALARIÉES DE 40 À 50 ANS
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) dated November 21, 2023. It announces a partnership between PREDILIFE and SOCAMAINE regarding breast cancer prevention screenings for employees. This type of announcement, detailing a specific business event, partnership, or corporate social responsibility initiative, is typically classified as a general regulatory announcement or press release that doesn't fit into the highly specific financial filing categories (like 10-K, ER, or DIV). Given the options, the most appropriate general category for a non-standard, non-mandatory financial disclosure that is essentially a news announcement is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous announcements.
2023-11-21 French
PREDILIFE LANCE UNE ÉMISSION D'OBLIGATIONS CONVERTIBLES DE 3M EUR A UN TAUX DE 8,5% PAR AN SUR 5 ANS REMBOURSABLES IN FINE POUR DÉPLOYER SON OFFRE À L'INTERNATIONAL
Capital/Financing Update Classification · 1% confidence The document is a press release dated November 6, 2023, announcing the launch of a public offering of convertible bonds (OCEANE) for a nominal amount of 3 million euros. The text details the principal terms, objectives (financing international deployment), conversion prices, maturity dates (2028), and potential dilution effects. This clearly describes a corporate action related to raising capital through debt instruments that can convert into equity. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA/RNS), as it contains the substantive details of the financing event itself.
2023-11-06 French
PREDILIFE MET À DISPOSITION SON RAPPORT FINANCIER SEMESTRIEL 2023
Report Publication Announcement Classification · 1% confidence The document is a very short press release (974 characters) dated October 27, 2023. The title explicitly states: 'PREDILIFE MET À DISPOSITION SON RAPPORT FINANCIER SEMESTRIEL 2023' (PREDILIFE MAKES AVAILABLE ITS 2023 SEMI-ANNUAL FINANCIAL REPORT). The body confirms that the 'rapport financier semestriel au 30 juin 2023 a été mis à disposition du public' (semi-annual financial report as of June 30, 2023, has been made available to the public) and directs readers to the website for the full report. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or made available classifies as a Report Publication Announcement (RPA), not the comprehensive report itself (which would be an IR).
2023-10-27 French
LE GROUPE APICIL PROPOSE À SES ASSURÉES DE 40 A 49 ANS LE FINANCEMENT D'UN BILAN PRÉDICTIF DU CANCER DU SEIN
Regulatory Filings Classification · 1% confidence The document is a press release dated October 24, 2023, announcing a partnership between PREDILIFE and APICIL regarding the financing of a predictive breast cancer screening for APICIL's insured members. This announcement details a specific business agreement, a new service offering, and quotes management. It is not a formal regulatory filing (like 10-K, IR, or ER), nor is it a transcript, audit report, or director's dealing. It fits best under a general announcement category. Since it is a specific business development announcement that doesn't fit the highly specific categories like M&A (TAR) or Capital Change (CAP), it falls under the general Regulatory Filings/Announcements category (RNS) as a catch-all for significant, non-standard corporate news releases.
2023-10-24 French
LE CIAMT, SERVICE DE PREVENTION ET DE SANTE AU TRAVAIL AVEC 27 000 ENTREPRISES ADHERENTES, PROPOSE LE BILAN DE PREDICTION DU CANCER DU SEIN AUX BENEFICIAIRES DE 40 A 49 ANS
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) dated October 18, 2023. It announces a partnership between PREDILIFE and CIAMT regarding the offering of a breast cancer prediction assessment. This is a general announcement regarding a business development or partnership, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a press release announcing a business event, and it does not fit into the more specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate general category for a non-standard, non-financial-specific announcement is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory or significant corporate announcements that aren't covered elsewhere. Given the short length and press release format, RNS is the best fit among the available options for a general corporate announcement.
2023-10-18 French
REMBOURSEMENT EN SUISSE DES BILANS PREDILIFE PAR LE GROUPE MUTUEL
Earnings Release Classification · 1% confidence The document is a press release dated October 9, 2023, announcing a specific business development: the reimbursement of Predilife's predictive health assessments by Groupe Mutuel in Switzerland. This announcement details a partnership/commercial agreement related to health services and insurance coverage. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a transcript (CT). It is a specific business update concerning a commercial arrangement, which fits best under a general regulatory announcement or business update category. Since there is no specific code for 'Commercial Partnership Announcement' or 'Business Update', and it is a formal announcement of a significant event, the most appropriate general category is Regulatory Filings (RNS), as it is a formal communication to the market about a material event, or potentially a Capital/Financing Update (CAP) if the reimbursement implies a significant revenue stream, but the primary nature is an announcement of a service integration/reimbursement. Given the options, RNS serves as the best general regulatory announcement fallback for material news that isn't explicitly covered by other specific financial reports or corporate actions like dividends or share issues. The length (2919 chars) suggests it is the full announcement, not just a notice of publication (RPA). FY 2023
2023-10-09 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.